• Slider Image
  • Slider Image
  • Slider Image

In the Press

January 5, 2019

Healthy Living: Cancer deaths drop in U.S.

According to a study by the American Cancer Society, deaths from cancer have dropped steadily for 25 straight years, and Dr. James Murphy gives his expert opinion.


January 5, 2019

Stopping cancer from recruiting immune system double agents

Researchers, led by senior author Judy Varner, PhD, find a novel intervention that keeps tumors from enlisting myeloid cells to help them grow and spread.


January 3, 2019

An Errant Editing Enzyme Promotes Tumor Suppressor Loss and Leukemia Propagation

A research team led by senior author Dr. Catriona Jamieson found that the normal functions of the ADAR1 enzyme are hijacked by pre-malignant cells, leading to a cascade of molecular consequences that promote malignant transformation, dormant cancer stem cell generation and resistance to treatment.


January 2, 2019

Frontline Cancer: The season for family, health, hope and new beginnings

The Moores Cancer Center at UC San Diego Health is one of just a small group of centers worldwide that treat a high volume of GIST cases each year.


January 2, 2019

For biomedical industry, partial government shutdown a New Year's headache

UC San Diego researcher/oncologist Dr. Catriona Jamieson said that while work is currently moving ahead, a prolonged shutdown will increasingly interfere with research.


January 1, 2019

How personalized medicine is transforming your healthcare

This month's issue of National Geographic magazine features the story of Teresa McKeown, a patient advocate who will be speaking at our upcoming "Next Generation Precision Oncology" Symposium next month.


December 22, 2018

n=30 Next Step in Cancer Therapy: Personalized Vaccine?

The podcast features Tamara Strauss, the first patient to enroll in a first-of-its-kind clinical trial at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.


December 19, 2018

Preventing Pancreatic Cancer: A Q&A with Surgical Oncologist Andrew Lowy, MD

Led by Dr. Andrew Lowy, along with a multidisciplinary team with expertise in genetics, imaging, endoscopic procedures, surgery and nutrition, UC San Diego Health is creating a first-of-its-kind clinic to develop personalized prevention and early detection plans for high-risk patients seeking care at San Diego’s only NCI-designated Comprehensive Cancer Center.


December 13, 2018

Cash running short, California's stem cell agency defends its results

The California Institute for Regenerative Medicine, or CIRM, is drawing down the last of $3 billion in state bond money granted by voters in 2004 with Proposition 71. Article features MCC oncologist/researcher and CIRM grantee Dr. Catriona Jamieson.


December 12, 2018

UC San Diego to Partner with New Allen Institute for Immunology

In its initial phase, the Allen Institute for Immunology will focus on studies of two cancers (multiple myeloma and melanoma) and three autoimmune disorders — rheumatoid arthritis and inflammatory bowel disease, specifically ulcerative colitis and Crohn’s disease.


December 7, 2018

UC San Diego Researcher Gets $4 Million NCI Award to Study Cancer Drug Resistance, Spread

NCI has awarded David Cheresh, PhD, Distinguished Professor and vice chair of Pathology at University of California San Diego School of Medicine, with a $4.2 million Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.


December 6, 2018

O.C. nonprofit empowers those with rare diseases

A patient, Merak Mlikian Hatounian, connected with UC San Diego’s a href="http://profiles.ucsd.edu/jason.sicklick">Dr. Jason Sicklick, one of the few doctors in the world studying GIST.


December 4, 2018

New Cancer Immunotherapy Approach Turns Immune Cells into Tiny Anti-Tumor Drug Factories

In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs, with senior author Maurizio Zanetti.


December 4, 2018

Study: Immunotherapy Better than Chemotherapy for Subtype of Head and Neck Cancer

Randomized clinical trial shows pembrolizumab is more effective, safer than standard therapy for disease that progresses or recurs, said Ezra Cohen, MD, professor of medicine at University of California San Diego School of Medicine and corresponding author on the study.


December 3, 2018

UC San Diego Health is First in San Diego to offer CAR T-cell Therapy for Some Cancers

Following the Food and Drug Administration’s approval of chimeric antigen receptor (CAR) T-cell therapies for the treatment of certain types of non-Hodgkin lymphomas, UC San Diego Health was the first medical center in San Diego to be certified to offer this type of immunotherapy outside of a clinical trial.


November 29, 2018

Prevention and Screening Clinic at UC San Diego Health Helping to Reduce Pancreatic Cancer

Led by Dr. Andrew Lowy, a multidisciplinary team, with expertise in genetics, imaging, endoscopic procedures, surgery and nutrition, is creating one of the first-of-its-kind clinics to develop a personalized prevention and early detection plan for each high-risk patient seeking care at San Diego’s only National Cancer Institute-designated Comprehensive Cancer Center.


November 21, 2018

Coping With Head and Neck Cancer

Dr. Ezra Cohen weighs in on the discussion about patients with head and neck cancer facing physical, social and emotional issues that can add to existing mental health problems or give rise to new ones.


November 21, 2018

Frontline Cancer: 'Vaping' not necessarily healthier than smoking

Dr. Scott Lippman, Director of the Moores Cancer Center, chimes in on the national debate.


November 20, 2018

Stand Up To Cancer Grant Funds UC San Diego Health Research in Pancreatic Cancer

Lead investigators Tannishtha Reya, PhD and Dr. Andrew Lowy have been awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer.


November 19, 2018

Trial to assess ibrutinib-cirmtuzumab combination for B-cell malignancies

Dr. Tom Kipps and colleagues will conduct the phase 1b/phase 2 trial to investigate whether the addition of the monoclonal antibody cirmtuzumab to standard therapy with ibrutinib benefits patients with B-cell malignancies.


November 5, 2018

The Role of HPV Virus in Head & Neck Cancer

A study with collaborator in the laboratory of Dr. Trey Ideker identified several new protein interactions that were previously not known to cause cancer, expanding knowledge of the oncogenic roles of the HPV virus.


November 2, 2018

Tiny DNA modification has big impact on deadly tumors

A simple modification of a DNA base in small areas of the genome may explain why glioblastoma tumors are so deadly, researchers at Yale and the UCSD report Nov. 1 in the journal Cell, with senior author Dr. Jeremy Rich.


October 28, 2018

California’s low lung cancer rates saves nearly 5,000 lives

California’s low rate of lung cancer deaths saved nearly 5,000 lives in 2014 — and saved Californians at least $500 million just in that year, according to a CALmatters analysis in consultation with public health researchers, including John Pierce, PhD.


October 11, 2018

Hormone Therapy for Prostate Cancer Not Significantly Linked to Subsequent Dementia

A team of epidemiologists and doctors at UC San Diego School of Medicine and Veterans Affairs San Diego Health Care System investigated the association between ADT and dementia in over 45,000 veterans who were diagnosed with prostate cancer between 2001 and 2015.


October 5, 2018

"When Cancer Genomics Research Outpaces the Regulation of Genomics Data: Does the Patient Win Or Lose?"

We congratulate our summer student Alice Lu, for the incredible accomplishment of receiving 1st Prize – Best Poster Presentation at the 2018 International Cancer Education Conference (https://2018.attendicec.org/), held October 3 – 5, 2018 in Atlanta, Georgia. Authors: Alice Lu, BS, BA, Georgia Robins Sadler, BSN, MBA, PhD, and Ida Deichaite, PhD, UC San Diego Moores Cancer Center.


October 4, 2018

Dr. Cohen on Immunotherapeutic Advances in Head and Neck Cancer

Dr. Ezra Cohen discusses immunotherapeutic advances in head and neck cancer, including investigational combinations showing impressive efficacy.


September 30, 2018

Conquering cancer by attacking the disease’s genetic abnormalities

Comprehensive tumor profiling — in which individuals are matched with drugs that target specific genetic mutations or other abnormalities — is becoming a cornerstone of cancer treatment. This features Dr. Razelle Kurzrock.


September 30, 2018

An Oncologist on Why the Patient Partnership is Sacred

Dr. Barbara Parker, the medical director at UC San Diego Health's Moores Cancer Center, reveals why the dynamic is an important "obligation".


September 26, 2018

AI and Machine Learning for Clinical Trials – Examining 3 Current Applications

AI helped the Moores Cancer Center at UC San Diego Health shorten its study timelines by nearly 33% and reduce data errors by 20%.


» More Press


2019 Symposium


The 15th Moores Cancer Center Industry/Academia "Next Generation Precision Oncology" Symposium will be held on Thursday, February 21, 2019.

Confirmed Speakers:

Duane Roth Award Lecture
A Story of Drug Development: Taxol®, Tubulin and Tumors

Susan Band Horwitz, PhD

Distinguished Professor, Department of Molecular Pharmacology
Rose C. Falkenstein Chair in Cancer Research
Einstein College of Medicine

Keynote Speaker
Delivering on the Promise of Precision Oncology

Gordon Mills, MD, PhD

Director, Precision Oncology, Knight Cancer Institute
Director, SMMART Trials, Knight Cancer Institute
Wayne and Julie Drinkward Endowed Chair, Precision Oncology, Knight Cancer Institute
Professor, Cell, Developmental and Cancer Biology
OHSU Knight Cancer Institute


UC San Diego Welcome and Introduction
David Brenner, MD
Vice Chancellor, UC San Diego Health Sciences

Moores Cancer Center Introduction
Joseph Califano, MD
Physician in Chief, Professor of Surgery, UC San Diego Moores Cancer Center
Director, Head and Neck Cancer Center

Clinical Perspective: Targeting CTGF in Locally Advanced Pancreatic Cancer
Ewa Carrier, MD
Executive Director of Clinical Development, Fibrogen

Organizer Welcome
Ida Deichaite, PhD
Director, Industry Relations, UC San Diego Moores Cancer Center

Epigenetics in Glioblastoma
Laure Escoubet, PhD
Senior Director, Head of Epigenetic Drug Discovery, Celgene

Ryan Fukushima, MBA
Chief Operating Officer, Tempus

A bispecific antibody strategy to focus 4-1BB activation at sites of PD-L1 expression
Analeah Heidt, PhD
Vice President of Translational Research, Inhibrx

Malignant Deamination Drives Cancer Stem Cell Generation
Catriona Jamieson, MD, PhD
Deputy Director, UC San Diego Moores Cancer Center
Professor of Medicine and Chief, Division of Regenerative Medicine
Koman Family Presidential Endowed Chair in Cancer Research
Deputy Director, Sanford Stem Cell Clinical Center
Director, CIRM Alpha Stem Cell Clinic

There's No Place Like HOPE
Shumei Kato, MD
Assistant Clinical Professor, UC San Diego Moores Cancer Center

Moores Cancer Center Welcome
Scott Lippman, MD
Director, UC San Diego Moores Cancer Center

Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor
Yi Liu, PhD
Chief Scientific Officer and Senior Vice President, Wellspring Biosciences LLC

The Molecular Characterization of Men with Metastatic Castration Resistant Prostate Cancer
Rana McKay, MD
Assistant Professor of Medicine, UC San Diego Moores Cancer Center

There's No Place Like HOPE
Teresa McKeown
Patient Advocate

Therapeutic Susceptibility of KRAS-Mutant Cancers to MRTX1257, a Covalent KRASG12C Inhibitor
Peter Olson, PhD
Director of Research, Mirati Therapeutics

Use of Stem Cell Memory T Cells (Tscm) for the Creation of CAR-T Therapies with Superior Characteristics
Eric Ostertag, MD, PhD
CEO, Poseida Therapeutics

Chair, Immuno-Oncology Session
Sandip Patel, MD
Associate Professor, Medical Oncology/Hematology, UC San Diego Moores Cancer Center

Present and Future of Cabozantinib in GU Cancers
José Ricardo Pérez
Executive Medical Director, Medical Affairs, Exelixis

Targeting stem cell signals in cancer heterogeneity and therapy resistance
Tannishtha Reya, PhD
Professor, Pharmacology and Medicine, UC San Diego

The Control of Anti-Tumor Immunity and its Implications on Checkpoint Inhibitor Therapy
Shabnam Shalapour, PhD
Associate Professor of Pharmacology, UC San Diego

Transcriptional Components and Signatures to Characterize the Cellular State of Individual Tumors
Pablo Tamayo, PhD
Director, UCSD Center for Cancer Target Discovery and Development
Professor, Division of Medical Genetics, UC San Diego Moores Cancer Center

Drugging the Cancer Cell Cycle
Michael White, PhD
VP, Tumor Cell Biology, Chief Scientific Officer, Pfizer

Controlling CAR-T Cell Therapy
Travis Young, PhD
VP, Biologics, California Institute for Biomedical Research (Calibr)


2018 Symposium Featured Talks


The 14th Moores Cancer Center Industry/Academia Translational Oncology Symposium was held on Thursday, February 22, 2018. See the Agenda here.


Keynote Presentation: Duane Roth Award Lecture
Engineering T-Cells: The Sky is the Limit


Carl June, MD
University of Pennsylvania School of Medicine




Keynote Presentation:
A New Model for Translational Research in the Nonprofit Sector


Peter Schultz, PhD
California Institute for Biomedical Research



Welcome Remarks


Ida Deichaite, PhD, Symposium Organizer, UC San Diego Moores Cancer Center
Pradeep Khosla, PhD, Chancellor, UC San Diego



Welcome Remarks


Thomas Kipps, MD, PhD
Symposium Chair, UC San Diego Moores Cancer Center





In silico drug discovery of dual inhibitors of combinatorial synthetic lethality inhibitors in the era of prevision medical oncology; proof of concept


Donald Durden, MD, PhD
UC San Diego Moores Cancer Center


Visit our Symposium page for more Symposium Featured Talks.





2015 Symposium Slideshow



Thank you to all that came and participated in the 2015 Symposium - we hope you enjoy the memories!



2014 Translational Oncology Symposium

A decade of fostering collaborations, fueling innovation & saving lives



San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see below.



The article is available here.

  • Xconomy’s San Diego Life Sciences Roundup included Bob Klein’s Proposal presented at the Moores Cancer Center Symposium, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016.
         » Read Here
  • Xconomy's San Diego Life Sciences Roundup also included the Moores Cancer Center Symposium and Laura Esserman's acceptance of the Duane Roth Award.
         » Read Here
  • The San Diego Daily Transcript published an article about Dr. Esserman's acceptance of the Duane Roth Award and the Symposium.
         » Read Here
  • The San Diego Union Tribune wrote an article on the Symposium, namely the iSPY Trial and patient from the trial, San Diego Resident Heather Clark.
         » Read Here
  • Symposium Speaker Bob Klein was featured in a San Diego Union Tribune article, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016, presented at the Moores Cancer Center Symposium.
         » Read Here


Our Symposium Page




9th Symposium Featured on San Diego ABC 10 News




San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.

More In the Press